Pre-Forum Workshop Program
December 14, 2000
Morning Session
08:45-12:30
(Opent to public. Please register by e-mail or fax)

Bechtel Conference Center, Encina Hall, Stanford University

University Perspective	08:45-09:55
Stanford and Spin-Outs	Katharine Ku (Stanford)
Japan-US differences in university-industry cooperation	Robert Kneller (UT)
Mission Bay: The second wave of biotechnology	Christopher Scott, (UCSF)

Bay Area Bioventure Perspective	09:55-11:05
Tularik: Science and business overview	David Goeddel( Founder &CEO, Tularik)
Maxygen: Genesis and early development of a platform biotechnology company	Russell Howard (CEO, Maxygen)
Geron: Geron's roots of commercial success	Thomas Okarma (CEO, Geron)

Japanese Bioventure Perspective	11:20-12:30
Differences in the conditions for fostering venture businesses in the US and Japan	Hidetaka Fukuda (Director Japan External Trade Organization, SF Office)
Builiding a bioventure in Japan: a risky endeavor	Yasuhiro Furuichi (Director, Agene Research Institute)
Bioventure<->Venture Capital Relationship in Japan	Tadashi Matsumoto (CEO, ReqMed)

Afternoon Site Visits
Complimentary Box Lunch for Participants
UCSF Mission Bay,Tularik, Rigel, Applied Biosystems, Incyte
Bus departs Encina Hall at 1:00 pm.